Medical device companies could achieve lower costs, greater quality, and enhanced efficiency by adopting an Industry 4.0 manufacturing strategy.

BIOMEDigital Keynote Speaker Harel Gadot discusses the potential of surgical robotics in the session, “Surgical Robotics 5.0: The Future of Robotics in Healthcare.”

Intuitive Surgical is optimistic about its long-term prospects of surgical robotics, but COVID-19 uncertainties continue to impact the company in the interim.

Johnson & Johnson's third-quarter earnings suggest that orthopedic surgeons are prioritizing hips over knees as they work through their COVID-related backlog.

Medtronic CEO Geoff Martha says the company is becoming a more nimble and a more competitive organization.

The XACT robot is touted as the only hands-free robotic solution combining image-based planning and navigation with insertion and steering of various instruments.

COVID-19 threw a gargantuan curveball at medtech, but these industry predictions for 2020 have been surprisingly on point, so far. See what we got right and what we didn't.

Zimmer Biomet revenue across all categories exceeded analyst expectations in the second quarter, despite COVID-19 disruptions, and Rosa placements were also surprisingly strong.

This month marks the 20th anniversary of FDA clearing the da Vinci surgical robotics system for laparoscopic procedures.